In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

After-tax profit was 812 million euros compared with 740 million in the same period last year, Merck said Thursday. The ...

Modifi Bio’s founders discuss the journey from developing a cancer treatment drug to being acquired by Big Pharma.

Merck KGaA on Thursday reported a gain of 11.9% in adjusted quarterly earnings, helped by temporarily lower spending on drug ...

Germany's Merck KGaA has said it needs to double the ... electronics like liquid crystal display screens and semiconductor chemicals. That diversified model makes it a small player in pharma ...

While Merck's oral drug Molnupiravir has already been cleared by the United Kingdom to treat COVID-19, a Paraguayan laboratory has filed for its emergency registration in the South American ...

Green manufacturing technologies including biocatalysis, enzyme immobilization, and continuous manufacturing in a packed-bed reactor enabled Merck to produce investigational leukemia drug ...

It has invested $10m (€9m) to construct the new lab. SOD is a material ... Kim Woo-kyu, managing director of Merck Korea said, “Merck has acquired M Chemicals and opened the SOD application ...